Skip to main content

Health + Wellness

PTSD_sweating_FI
Sweating is a clue into who develops PTSD—and who doesn’t
Within four hours of a traumatic experience, certain physiological markers—namely, sweating—are higher in people who go on to develop posttraumatic stress disorder (PTSD), according to a new study by a researcher at Case Western Reserve University and other institutions. Around 90% of people who…
brain-scan-feat
Case Western Reserve ‘spinout’ company, Convelo Therapeutics, partners with Genentech to develop medicines for neurological disorders
Convelo Therapeutics Inc., a Cleveland company based on the research findings of Paul Tesar and Drew Adams at the Case Western Reserve University School of Medicine, has entered into a strategic partnership with Genentech to develop new therapeutic drugs to repair damaged myelin insulation on nerve…
Responsive-teaching
Study finds lower stress, depression levels in mothers of children with autism by improving relationships
Mothers of young children with autism who focus on improving the quality of their own relationship skills—as opposed to teaching developmental skills to their children—experience dramatic improvements in their level of parenting stress and depression. That’s according to a new research study…
Researchers Discover New Combination Therapy to Treat Drug-Resistant Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia accounts for one in five adult leukemias, and is the most common pediatric cancer in the United States. While new immune therapies have helped improve survival rates, some patients are unresponsive to existing treatment regimens. In addition, drug-related toxicities and…
GettyImages-187272969
Cleveland researchers recruiting for Alzheimer’s disease clinical trial
CWRU School of Medicine and UH Cleveland Medical Center study to measure the drug efavirenz’s potential improvement in people with early onset Alzheimer’s disease Case Western Reserve University School of Medicine and University Hospitals (UH) Cleveland Medical Center have enrolled their first…
High-Tech Imagery May Lead to New Drugs to Treat Therapy-Induced Nausea in Cancer Patients
Outlet: Genetic Engineering & Biotechnology News
New, High-Resolution Images Reveal Clues to Improve Anti-Nausea Drugs for Cancer Patients
A new study using a special type of electron microscope using samples cooled to extremely cold temperatures provides critical information for drug developers seeking to reduce nausea and vomiting side effects of cancer treatments. Published in Nature Communications, the study offers a glimpse into…
Schiemann to Lead Athymic Animal and Preclinical Therapeutics Shared Resource
We are pleased to announce that  William Schiemann, PhD has accepted the role of Director of the Case Comprehensive Cancer Center's Athymic Animal and Preclinical Therapeutics Shared Resource. Schiemann joins co-Director Daniel Lindner, MD, PhD in leading the two-location facility at Case Western…
Probiotic Could Disrupt Crohn’s Disease Biofilms
Outlet: Today's Dietitian